Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS)
Abstract Introduction Approximately one-third of psoriasis cases present in the first two decades of life. Many psoriasis treatments are approved by the U.S. Food and Drug Administration (FDA) for adults, including topical agents, systemic non-biologic agents, and systemic biologic agents. Only a ha...
Main Authors: | Rachel E. Tao, Jessica N. Pixley, Phillip G. Holovach, Alan B. Fleischer, Steven R. Feldman |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-10-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-023-01051-6 |
Similar Items
-
Analysis of pediatric outpatient visits uncovers disparities in molluscum contagiosum treatment across medical specialties in the United States
by: Karan Rajalingam, et al.
Published: (2023-10-01) -
Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series
by: Henrietta Albela, et al.
Published: (2022-04-01) -
In psoriasis treatment, greater improvement in skin severity predicts greater improvement in nail severity
by: Amanda M. Rusk, et al.
Published: (2021-11-01) -
Collaborative practice trends in US physician office visits: an analysis of the National Ambulatory Medical Care Survey (NAMCS), 2007–2016
by: Shahpar Najmabadi, et al.
Published: (2020-06-01) -
Topical treatment of psoriasis
by: Sylwia Skwira, et al.
Published: (2022-12-01)